These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9447452)

  • 41. Ovarian Response and in Vitro Fertilization Outcomes After Salpingectomy: Does Salpingectomy Indication Matter?
    Pereira N; Pryor KP; Voskuilen-Gonzalez A; Lekovich JP; Elias RT; Spandorfer SD; Rosenwaks Z
    J Minim Invasive Gynecol; 2017; 24(3):446-454.e1. PubMed ID: 28069482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis.
    Hamdan M; Dunselman G; Li TC; Cheong Y
    Hum Reprod Update; 2015; 21(6):809-25. PubMed ID: 26168799
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical applications of different doses of leuprorelin acetate in in vitro fertilization-embryo transfer].
    Wang L; Zhang WX; Jiang H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):910-4. PubMed ID: 23324190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of supraphysiologic estradiol levels on human nidation.
    Gelety TJ; Buyalos RP
    J Assist Reprod Genet; 1995 Aug; 12(7):406-12. PubMed ID: 8574066
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ovarian response to gonadotropins in patients with tubal factor infertility: salpingectomy versus nonsalpingectomy.
    Lin YJ; Ou YC; Huang FJ; Lin PY; Kung FT; Lan KC
    J Minim Invasive Gynecol; 2013; 20(5):637-41. PubMed ID: 23706676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Impact of laparoscopic surgery of peritoneal endometriosis and endometrioma on the outcome of ICSI cycles.
    Guler I; Erdem A; Oguz Y; Cevher F; Mutlu MF; Bozkurt N; Oktem M; Erdem M
    Syst Biol Reprod Med; 2017 Oct; 63(5):324-330. PubMed ID: 28609124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IVF outcome in women with accidental contamination of follicular fluid with endometrioma content.
    Benaglia L; Cardellicchio L; Guarneri C; Paffoni A; Restelli L; Somigliana E; Fedele L
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():130-4. PubMed ID: 25150950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Consecutive gonadotropin-releasing hormone-antagonist in vitro fertilization cycles: does the elapsed time interval between successive treatments affect outcomes?
    Reichman DE; Chung P; Meyer L; Greenwood E; Davis O; Rosenwaks Z
    Fertil Steril; 2013 Apr; 99(5):1277-82. PubMed ID: 23290740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of ovarian endometrioma on embryo quality.
    Reinblatt SL; Ishai L; Shehata F; Son WY; Tulandi T; Almog B
    Fertil Steril; 2011 Jun; 95(8):2700-2. PubMed ID: 21444070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction-intrauterine insemination to in vitro fertilization conversions, independent of age and estradiol level on the day of human chorionic gonadotropin administration.
    Quaas AM; Missmer SA; Ginsburg ES
    Fertil Steril; 2010 Feb; 93(2):605-8. PubMed ID: 19324340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impacts of medroxyprogesterone acetate on oocytes and embryos: matched case-control study in women with stage III-IV ovarian endometriosis undergoing controlled ovarian hyperstimulation for
    Guo H; Gao H; Li J; Cong Y; Chen Q; Wang Y; Zhu Q; Lyu Q; Wu L; Chai W; Kuang Y
    Ann Transl Med; 2020 Mar; 8(6):377. PubMed ID: 32355821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bilaterality of ovarian endometriomas does not affect the outcome of in vitro fertilization/intracytoplasmic sperm injection in infertile women after laparoscopic cystectomy.
    Yu HT; Huang HY; Tseng HJ; Wang CJ; Lee CL; Soong YK
    Biomed J; 2017 Oct; 40(5):295-299. PubMed ID: 29179885
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparison of the efficiency between in-vitro maturation and in-vitro fertilization after early follicular phase GnRH agonist down-regulation in infertile women with polycystic ovary syndrome].
    Zhu RR; Xiao SQ; Zhao JZ; Lin J; Wang PY; Jin CC; Jin WM
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):833-7. PubMed ID: 24444560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro fertilization outcome in women with endometriosis & previous ovarian surgery.
    Pop-Trajkovic S; Kopitovic V; Popovic J; Antic V; Radovic D; Zivadinovic R
    Indian J Med Res; 2014 Sep; 140(3):387-91. PubMed ID: 25366206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.